Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Stefano SainasAgnese C PippioneElisa LupinoMarta GiorgisPaola CircostaValentina GaidanoParveen GoyalDavide BonanniBarbara RolandoAlessandro CignettiAlex DucimeMikael AnderssonMichael A JärvåRosmarie FriemannMarco PiccininiCristina RamondettiBarbara BuccinnàSalam Al-KaradaghiDonatella BoschiGiuseppe SaglioMarco Lucio LolliPublished in: Journal of medicinal chemistry (2019)